Vince S Yeh

USPTO Granted Patents = 26 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 9.3

ph-index = 5

Forward Citations = 69(Granted Patents)

Location History:

Chicago, IL (US) (2007 - 2009)
LaJolla, CA (US) (2015 - 2016)
San Diego, CA (US) (2010 - 2021)

Company Filing History:

Abbott Laboratories Corporation

5. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2021

Loading Chart...

26 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11123348 - Compounds and compositions for the treatment of parasitic diseases (2021-09-21),

2. 10596175 - Compounds and compositions for the treatment of parasitic diseases (2020-03-24),

3. 10085989 - Compounds and compositions for the treatment of parasitic diseases (2018-10-02),

4. 9751876 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension (2017-09-05),

5. 9700559 - Compounds and compositions for the treatment of parasitic diseases (2017-07-11),

6. 9464072 - Treatment of central nervous system disorders (2016-10-11),

7. 9303034 - Compounds and compositions for the treatment of parasitic diseases (2016-04-05),

8. 9290444 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2016-03-22),

9. 9199981 - Compounds and compositions as C-kit kinase inhibitors (2015-12-01),

10. 9073921 - Salt forms of bicyclic heterocyclic derivatives (2015-07-07),

11. 9023839 - Compounds and compositions as c-kit kinase inhibitors (2015-05-05),

12. 8993632 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme (2015-03-31),

13. 8940902 - Treatment of central nervous system disorders (2015-01-27),

14. 8883819 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension (2014-11-11),

15. 8754071 - Compounds and compositions as c-kit kinase inhibitors (2014-06-17),

Certainly! Here is an article about the accomplished inventor Vince S Yeh:

Title: The Innovative Work of Inventor Vince S Yeh

Introduction:

In the realm of pharmaceutical innovations, one name shines brightly – that of inventor Vince S Yeh. Hailing from the vibrant city of Chicago, IL (US), Vince S Yeh has made significant contributions to the field of medicine through his groundbreaking inventions.

Latest Patents:

Vince S Yeh's latest patents revolve around compounds and compositions for the treatment of parasitic diseases. His inventions provide compounds of Formula A, along with pharmaceutical compositions comprising these compounds, aimed at treating diseases caused by parasites such as leishmaniasis, human African trypanosomiasis, and Chagas disease.

Career Highlights:

With an impressive portfolio of 26 patents, Vince S Yeh has demonstrated a keen focus on improving healthcare outcomes through innovation. He has lent his expertise to renowned companies such as Novartis AG and Abbott Laboratories Corporation, where his inventive spirit has driven advancements in the field of medicine.

Collaborations:

In his journey towards pioneering medical solutions, Vince S Yeh has collaborated with esteemed professionals in the industry. Some of his notable coworkers include James T Link and Jeffrey J Rohde, who have worked alongside Vince in shaping the landscape of pharmaceutical research and development.

Conclusion:

In conclusion, Vince S Yeh stands as a beacon of innovation in the realm of healthcare. His relentless pursuit of novel solutions for combating parasitic diseases has not only enriched the field of medicine but has also offered hope to those affected by such conditions. With a legacy of 26 patents and counting, Vince S Yeh continues to inspire future generations of inventors and researchers in the quest for a healthier world.

I hope you find this article insightful and informative about the remarkable inventor Vince S Yeh.

This text is generated by artificial intelligence and may not be accurate.